According to the agreement with the goverment of the Republic of Uzbekistan, in September 2018 it was decided to construct a modern pharmaceutical production by Foreign investors in Tashkent, meeting the requirements of the international GMP standard (good manufacturing practice). Foreign Company Belpharm LLC was established in January 2019 and launched the project in October 2019.
Estimated launch date: First production line: I quarter of 2022. Second production line: I quarter of 2024.